Trial NCT00317434

View at ClinicalTrials.gov 
Org. Study IDs: UAB 0538 - F051025014
Secondary IDs: 104239

Last trial update was posted on 2009-12-15

MeSH Interventions

Lapatinib

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

Due to unacceptable non-dose limiting toxicities, excessive treatment delays and limited clinical responses.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID